Insulin detemir Subcutaneous and Mogamulizumab-kpkc Intravenous
Determining the interaction of Insulin detemir Subcutaneous and Mogamulizumab-kpkc Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Molindone
- Insulin detemir Subcutaneous-Mometasone (Oral Inhalation)
- Insulin detemir Subcutaneous-Mometasone and Formoterol
- Insulin detemir Subcutaneous-Mometasone and formoterol Inhalation
- Insulin detemir Subcutaneous-Mometasone Cream
- Insulin detemir Subcutaneous-Mometasone Furoate
- Mogamulizumab-kpkc Intravenous-Insulin glargine
- Mogamulizumab-kpkc Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Mogamulizumab-kpkc Intravenous-Insulin Glargine (U-100) Vials
- Mogamulizumab-kpkc Intravenous-Insulin Glargine (U-300) Pens
- Mogamulizumab-kpkc Intravenous-Insulin glargine and lixisenatide
- Mogamulizumab-kpkc Intravenous-Insulin glargine and lixisenatide Subcutaneous